Outlook Therapeutics, Inc.
OTLK· Nasdaq
OTLKOutlook Therapeutics, Inc.
Outlook Therapeutics, Inc.’s Q4 2026 10-K window runs Dec 16, 2026 to Dec 30, 2026.
Based on 8 prior 10-K filings.
Outlook Therapeutics, Inc. · CIK 1649989 · Engraved from SEC EDGAR
